Results 231 to 240 of about 256,219 (295)

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments. [PDF]

Comput Struct Biotechnol J
Todsaporn D, Sanachai K, Aonbangkhen C, Geronikaki A, Kartsev V, Lichitsky B, Komogortsev A, Maitarad P, Rungrotmongkol T.   +8 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Toward clone‐on‐a‐chip: Ethical and legal considerations for organ‐on‐a‐chip evolution

BMEMat, EarlyView.
The term “clone‐on‐a‐chip (CoC)” is introduced as a conceptual warning for personalized organ‐on‐a‐chip platforms and not to suggest technological feasibility, where a CoC ethical discussion extends beyond issues arising from the requirements for informed consent, property rights, commercialization efforts, and cell sourcing to include potentially ...
Muhammed Erkan Karabekmez, Aliakbar Ebrahimi, Hamed Ghorbanpoor, Nicole Bassous, Su Ryon Shin, Yu Shrike Zhang, Huseyin Avci   +6 more
wiley   +1 more source

Effects of fluid shear stress duration on the mechanical properties of HeLa cells using atomic force microscopy. [PDF]

PLoS One
Zhao X, Zhang X, Lei F, Guo W, Yu H, Wang Y.   +5 more
europepmc   +1 more source

RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression. [PDF]

Clinics (Sao Paulo)
Zeng Z, Mai M, Wang D, Ouyang J, Chen Z, Zhong J, Rao J.   +6 more
europepmc   +1 more source

Deacidification of the Endolysosomal System by the Vesicular Proton Pump V-ATPase Inhibitor Bafilomycin A1 Affects EGF Receptor Endocytosis Differently in Endometrial MSC and HeLa Cells. [PDF]

Int J Mol Sci
Salova AV, Belyaeva TN, Litvinov IK, Kharchenko MV, Kornilova ES.   +4 more
europepmc   +1 more source

The Yarkand hare epidermal growth factor receptor improves the survival and antioxidant capacity of HeLa cells under stress. [PDF]

Curr Zool
Cui Y, Xu M, Duan M, Wu J, Zhou Y, Shan W.   +5 more
europepmc   +1 more source

D-M159 Synergistically Induces Apoptosis in HeLa Cells Through Endoplasmic Reticulum Stress and Mitochondrial Dysfunction. [PDF]

Int J Mol Sci
Li Y, Li D, Jiang Z, Yuan Z, Sun Z, Sun L.   +5 more
europepmc   +1 more source

Chemical profiling and anticancer activity of Alnus incana dichloromethane fraction on HeLa cells via cell cycle arrest and apoptosis. [PDF]

BMC Complement Med Ther
Hesham W, Elzayat EM, Hosney M, Abo-Elghiet F.   +3 more
europepmc   +1 more source